{"id":12101,"date":"2026-02-18T20:43:26","date_gmt":"2026-02-18T20:43:26","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/12101\/"},"modified":"2026-02-18T20:43:26","modified_gmt":"2026-02-18T20:43:26","slug":"astrazeneca-genentech-roche-takeda-day-3-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/12101\/","title":{"rendered":"AstraZeneca, Genentech, Roche, Takeda Day 3 news"},"content":{"rendered":"

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud<\/a> and author of the newsletter Adam\u2019s Biotech Scorecard.<\/a> You can reach Adam on Signal at stataf.54.<\/p>\n

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His work has been recognized by national Edward R. Murrow awards, the June L. Biedler prize for cancer journalism, and more. You can reach Angus on Signal at angus.08.<\/p>\n

This is the web version of STAT\u2019s\u00a0special newslette<\/a>r from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter\u00a0here<\/a>.<\/p>\n

We\u2019re going to get to today\u2019s new data in a minute, but first let\u2019s deal\u00a0with a less serious matter:\u00a0the marketing of pharmaceutical products via the food attendees need to consume at giant medical meetings.<\/p>\n

Genentech has been a longtime leader on this front. At cancer meetings, the cookies the company hands out at its booths are almost as famous as its drugs. An innovation this year: Genentech s\u2019mores, with Genentech-branded marshmallows toasted with a blowtorch. Warning: These things are messy. Other innovations in booth food: Novartis had charcuterie (guys, you know preserved meat is carcinogenic, right?) and Eli Lilly had a salad bar. The lettuce did not have a Lilly logo.<\/p>\n

STAT+ Exclusive Story<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\"STAT+\"\/<\/p>\n

\t\t\t\t\t
\n\t\t\t\t\t\t\"STAT+\"\/
\n\t\t\t\t\t<\/a><\/p>\n

\t\t\t\tThis article is exclusive to STAT+ subscribers
\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\t\t\tIndividual plans<\/p>\n

\t\t\t\t\t\tGroup plans<\/p>\n

\t\t\t\tView All Plans<\/a><\/p>\n

\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n

\t\t\t\t\tSubscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…\n","protected":false},"author":2,"featured_media":12102,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[8985,336,2112,324,337,338,134],"class_list":["post-12101","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-asco","tag-biotechnology","tag-cancer","tag-drug-development","tag-pharmaceuticals","tag-research","tag-roche"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/12101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=12101"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/12101\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/12102"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=12101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=12101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=12101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}